CYH:NYSECommunity Health Systems, Inc. Analysis
Data as of 2026-03-28 - not real-time
$2.86
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Community Health Systems is trading at $2.86, well below its 20‑day ($3.17), 50‑day ($3.25) and 200‑day ($3.21) simple moving averages, indicating a bearish technical backdrop. The RSI sits at 34, hinting at oversold conditions, yet the MACD remains bearish and price is barely above the identified support of $2.83, with resistance near $3.64. Fundamentally, the stock appears extremely cheap – a trailing PE of 0.76 versus an industry average of 25 – but this discount is driven by a distressed balance sheet: $11.0 B of debt dwarfs $0.26 B of cash, book value per share is negative, and forward EPS is projected to be slightly negative. Revenue has contracted 5% year‑over‑year to $12.5 B, though same‑store net revenue grew 2.1% in the latest quarter and per‑admission revenue rose 2.4%, suggesting modest operational resilience. The company reported improved operating cash flow ($543 M) and free cash flow ($395 M) while divesting assets to trim debt, but the heavy leverage and negative equity keep risk elevated.
Overall, the stock sits at a crossroads between a potentially deep value opportunity and significant financial headwinds, with market sentiment currently leaning toward “Greed” (Fear & Greed Index 66) despite high volatility (48% 30‑day) and a beta above 1.
Overall, the stock sits at a crossroads between a potentially deep value opportunity and significant financial headwinds, with market sentiment currently leaning toward “Greed” (Fear & Greed Index 66) despite high volatility (48% 30‑day) and a beta above 1.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above technical support
- Bearish MACD and RSI indicating limited upside
- Recent mixed earnings and revenue miss
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Asset divestitures expected to reduce leverage
- Improving same‑store revenue trends
- Significant valuation discount relative to peers
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt load and negative book value limit upside
- Healthcare sector exposure to policy and reimbursement risk
- Potential for gradual recovery if cash‑flow improvements persist
Key Metrics & Analysis
Financial Health
Revenue Growth-4.90%
Profit Margin4.08%
P/E Ratio0.8
ROA4.96%
P/B Ratio-0.3
Op. Cash Flow$543.0M
Free Cash Flow$395.2M
Industry P/E25.0
Technical Analysis
TrendNeutral
RSI34.3
Support$2.83
Resistance$3.64
MA 20$3.17
MA 50$3.24
MA 200$3.21
MACDBearish
VolumeStable
Fear & Greed Index65.98
Valuation
Target Price$3.60
Upside/Downside25.87%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.16
Volatility48.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.